Nuvation Bio Inc. SEC filings NUVB
Nuvation Bio Inc. has 400 filings in SEC EDGAR's recent list, going back to May 15, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 305B2 | Filing | Jun 29, 2026 | — |
| 25-NSE | Delisting notice | Feb 10, 2026 | — |
| EFFECT | Filing | Aug 15, 2024 | — |
| DEFR14A | Filing | Aug 13, 2024 | — |
| CORRESP | Letter to the SEC | Aug 12, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2024 | — |
| CORRESP | Letter to the SEC | Jul 16, 2024 | — |
| PRER14A | Filing | Jul 16, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2024 | — |
| CORRESP | Letter to the SEC | Jun 18, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2024 | — |
| PRER14A | Filing | May 24, 2024 | — |
| EFFECT | Filing | Apr 7, 2022 | — |
| EFFECT | Filing | May 28, 2021 | — |
| EFFECT | Filing | Mar 31, 2021 | — |
| CORRESP | Letter to the SEC | Mar 29, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2021 | — |
| 25-NSE | Delisting notice | Feb 11, 2021 | — |
| EFFECT | Filing | Jan 20, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| SEC STAFF LETTER | Filing | Jan 19, 2021 | — |
| CORRESP | Letter to the SEC | Jan 8, 2021 | — |
| 425 | Filing | Jan 8, 2021 | — |
| 425 | Filing | Jan 5, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 30, 2020 | — |
| CORRESP | Letter to the SEC | Dec 18, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2020 | — |
| 425 | Form 425 | Oct 23, 2020 | — |
| 425 | Filing | Oct 23, 2020 | — |
| 425 | Filing | Oct 23, 2020 | — |
| 425 | Form 425 | Oct 21, 2020 | — |
| 425 | Current report | Oct 21, 2020 | — |
| EFFECT | Filing | Jun 30, 2020 | — |
| CERT | Nyse certification filing | Jun 29, 2020 | — |
| 8-A12B | Registration of certain classes of securities | Jun 26, 2020 | — |
| DRS | Filing | May 15, 2020 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NUVB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1811063
- Former names
- Panacea Acquisition Corp (until Feb 11, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.